Kanchi Chadha, MD, FACOG, MSCP, supports reconsidering MHT boxed warnings but says the FDA cited no study behind the change.

This FAQ summarizes a Special Report discussion of what the evidence does and does not establish about testosterone therapy ...

Soma Mandal, MD, MSCP, says removing MHT boxed warnings is overdue but calls for transparency on the FDA's product-specific ...

Swanson, PhD, on a pilot in which integrative group medical visits improved menopause symptoms, knowledge, and self-efficacy.

HRSA will award up to $1 million to a single organization to update the Women's Preventive Services Guidelines through the new WISH program.

Chrisandra Shufelt, MD, on why menopause is a window for cardiovascular prevention and the risk factors OB/GYNs should assess ...

Chrisandra L. Shufelt, MD, MS, FACP, MSCP, professor and chair of the Division of General Internal Medicine and associate ...

The FDA granted accelerated approval to Voceryq to reduce papilloma excision surgeries in adults with recurrent respiratory papillomatosis.

CMS' proposed G-codes, which experts stated would cause confusion in combination with the AMA's proposed codes, were not ...

Nearly half of menopausal sleep disruption tracks with nighttime hot flashes, while the remainder appears independent, making ...

Sleep disturbance is often the most bothersome symptom of the menopause transition, yet it frequently goes unreported unless ...

Matthew Nudy, MD, on estrogen's cardiovascular effects, risk assessment, and hormone therapy safety in younger menopausal ...